We are live on
!
Find out more
Agios Pharmaceuticals
AGIO
AGIO
224 hedge funds and large institutions have $1.97B invested in Agios Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 85 increasing their positions, 71 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
71% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 24
20% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 71
8% more funds holding
Funds holding: 207 → 224 (+17)
2.79% more ownership
Funds ownership: 102.15% → 104.94% (+2.8%)
22% less call options, than puts
Call options by funds: $9.02M | Put options by funds: $11.5M
24% less capital invested
Capital invested by funds: $2.58B → $1.97B (-$616M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
224
Holders Change
+17
Holders Change %
+8.21%
% of All Funds
2.95%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
41
Increased
85
Reduced
71
Closed
24
Calls
$9.02M
Puts
$11.5M
Net Calls
-$2.48M
Net Calls Change
+$744K
Top Buyers
| 1 |
JFG
Jefferies Financial Group
New York
|
+$70.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$66.8M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$14.2M |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$13M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12.5M |
Top Sellers
| 1 |
VPC
Vestal Point Capital
New York
|
-$33.8M |
| 2 |
JP Morgan Chase
New York
|
-$32.8M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$29.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$19.2M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$17.6M |
